Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | RAB9A | P51151 | 2/20 | 0.62 |
| ▸ | GAA | P10253 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | PKM | P14618 | 2/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.57 |
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | CA4 | P22748 | 1/20 | 0.56 |
| ▸ | CA6 | P23280 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10830995 | 0.93 | TSHR (0.67) | TSHRALDH1A1RAB9AGAAKDM4E | |
| SCHEMBL6550416 | 0.90 | TSHR (0.75) | TSHRALDH1A1RAB9AGAAKDM4E | |
| SCHEMBL76834 | 0.88 | TSHR (0.73) | TSHRALDH1A1GAASMN1; SMN2L3MBTL1 | |
| SCHEMBL29399077 | 0.88 | TSHR (0.73) | TSHRALDH1A1GAASMN1; SMN2L3MBTL1 | |
| SCHEMBL27753902 | 0.88 | TSHR (0.73) | TSHRALDH1A1GAASMN1; SMN2L3MBTL1 | |
| SCHEMBL111732 | 0.87 | TSHR (1.00) | TSHRALDH1A1RAB9AGAAKDM4E | |
| SCHEMBL23467802 | 0.86 | TSHR (0.73) | TSHRALDH1A1RAB9AGAAKDM4E | |
| SCHEMBL30743049 | 0.86 | TSHR (0.73) | TSHRALDH1A1RAB9AGAAKDM4E | |
| SCHEMBL17184498 | 0.86 | TSHR (0.73) | TSHRALDH1A1RAB9AGAAKDM4E | |
| SCHEMBL13775494 | 0.86 | TSHR (0.73) | TSHRALDH1A1RAB9AGAAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102459291-A | Neuroprotective compounds and their use | MCW RES FOUND INC (US) | 2012-05-16 | — | — | CN | claimed |
| EP-4251708-B1 | METHOD FOR PRODUCING A HIGH-PHENOLIC-CONTENT BIOOIL | THE UNIV OF NEW BRUNSWICK (CA) | 2026-02-11 | — | — | EP | disclosed |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12458653-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-11-04 | — | — | US | disclosed |
| US-12303488-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-05-20 | — | — | US | disclosed |
| EP-4417252-A2 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | Yuzu LV LLC (US) | 2024-08-21 | — | — | EP | disclosed |
| US-20230365764-A1 | METHOD FOR PRODUCING A HIGH-PHENOLIC-CONTENT BIOOIL | THE UNIVERSITY OF NEW BRUNSWICK (CA) | 2023-11-16 | — | — | US | disclosed |
| US-20230346739-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC | 2023-11-02 | — | — | US | disclosed |
| US-20230293480-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC | 2023-09-21 | — | — | US | disclosed |
| US-20230293555-A1 | COMPOSITIONS COMPRISING CANNABIDIOL AND FLAVANONES | YUZU LV LLC | 2023-09-21 | — | — | US | disclosed |
| EP-2069321-A1 | NOVEL BENZOFURAN TYPE DERIVATIVES, A COMPOSITION COMPRISING THE SAME FOR TREATING OR PREVENTING COGNITIVE DYSFUNCTION AND THE USE THEREOF | Digital Biotech Co., Ltd. (KR) | 2009-06-17 | — | — | EP | disclosed |
| WO-2008041826-A1 | NOVEL BENZOFURAN TYPE DERIVATIVES, A COMPOSITION COMPRISING THE SAME FOR TREATING OR PREVENTING COGNITIVE DYSFUNCTION AND THE USE THEREOF | DIGITAL BIOTECH CO., LTD (KR) | 2008-04-10 | — | — | WO | disclosed |
| US-20070259333-A1 | NOVEL ZWITTERIONIC DYES FOR LABELING IN PROTEOMIC AND OTHER BIOLOGICAL ANALYSES | MONTANA STATE UNIVERSITY (US) | 2007-11-08 | — | — | US | disclosed |
| US-20070259333-A1 | NOVEL ZWITTERIONIC DYES FOR LABELING IN PROTEOMIC AND OTHER BIOLOGICAL ANALYSES | MONTANA STATE UNIVERSITY (US) | 2007-11-08 | — | — | US | disclosed |
| CN-1923790-A | Kutkin derivative, preparation method and application thereof | UNIV JINAN (CN) | 2007-03-07 | — | — | CN | disclosed |
| US-20070037739-A1 | Compounds useful in coating stents to prevent and treat stenosis and restenosis | MEDLOGICS DEVICE CORPORATION (US) | 2007-02-15 | — | — | US | disclosed |
| US-20070037739-A1 | Compounds useful in coating stents to prevent and treat stenosis and restenosis | MEDLOGICS DEVICE CORPORATION (US) | 2007-02-15 | — | — | US | disclosed |
| US-20070037739-A1 | Compounds useful in coating stents to prevent and treat stenosis and restenosis | MEDLOGICS DEVICE CORPORATION (US) | 2007-02-15 | — | — | US | disclosed |
| US-20070032477-A1 | Pteridine derivatives useful for making pharmaceutical compositions | 4 AZA BIOSCIENCE NV (BE) | 2007-02-08 | — | — | US | disclosed |
| WO-2004069201-A2 | COMPOUNDS USEFUL IN COATING STENTS TO PREVENT AND TREAT STENOSIS AND RESTENOSIS | MEDLOGICS DEVICE CORPORATION (US) | 2004-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | CNR1, CNR2, OPRM1 | TSHR 4394/4885ALDH1A1 1420/4885RAB9A 1595/4885 |
| US-20070032477-A1 | Pteridine derivatives useful for making pharmaceutical compositions | TPMT, TYMS, TNF | TSHR 4732/4885ALDH1A1 1733/4885RAB9A 1816/4885 |
| US-20070037739-A1 | Compounds useful in coating stents to prevent and treat stenosis and restenosis | CAD, DBNL, DCAF15 | TSHR 4614/4885ALDH1A1 3734/4885RAB9A 4110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.